Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007

In order to examine the efficacy and side effects of the monoclonal antibody anti-CD20 (rituximab) on autoimmune blistering skin diseases, we performed a comprehensive survey of 71 consecutive patients from initial use up to 2007, using the PubMed database. A heterogeneous group of patients, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Jennifer D, Chan, Lawrence S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697541/
https://www.ncbi.nlm.nih.gov/pubmed/19436603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697541/
https://www.ncbi.nlm.nih.gov/pubmed/19436603

Ejemplares similares